|
|
| MRD / Regn No. |
: 20180000896 |
Date |
: 23/07/2026 |
| Patient Name |
: Govindaraj Ganesan |
Age & Gender |
: 43 Yrs. / Male |
| Contact No. |
: 9500032308 |
UHID |
: |
| Ht / Wt / BMI |
: 177.5 / 77.2 / 24.50 |
BP S / BP D |
: 134 / 92 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
ERECTILE DYSFUNCTION (01/Jan/2015) | TYPE 2 DM (01/Jan/2014) | VITAMIN D DEFICIENCY (14/Jul/2022) | HYPERTRIGLYCERIDEMIA (08/Jan/2024) | PARONYCHIA (08/Jan/2024) | |
|
Subjective |
: |
LOST TO FOLLOW UP
|
|
Objective |
: |
NONE |
|
Analysis |
: |
T2DM,ERECTILE DYSFUNCTION,VITAMIN DEFICIENCY,HYPERTRIGLYCERIDEMIA,A2G1 DKD |
|
Plan |
: |
ADD SEMAGLUTIDE,SEE ME IN 1 MONTH |
|
| Salient Investigations |
: |
HEMOGLOBIN: 16.1 g/dL | MCV - MEAN CORPUSCULAR VOLUME: 84.4 fL | PLATELETS: 225 thou cells/ ul | WBC WHITE BLOOD CELLS: 729 K/uL | FASTING PLASMA GLUCOSE (FPG): 173 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 9.5 % | URINE MICROALBUMINURIA: 0.8 mg/L | BICARBONATE: 23 meq/L | CHLORIDE: 101 meq/L | POTASSIUM: 4.2 meQ/L | SODIUM: 137 meq/L | CREATININE: 0.8 mg/dL | UREA: 15.9 mg/dL | URIC ACID: 5.2 | HDL HIGH DENSITY LIPOPROTEIN: 25 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 41 mg/dL | TGL TRIGLYCERIDE: 164 mg/dL | TOTAL CHOLESTEROL: 86 mg/dl | BUN BLOOD UREA NITROGEN: 7.4 mg/dL | HEMOGLOBIN: 16.1 g/dL | MCV - MEAN CORPUSCULAR VOLUME: 84.4 fL | PLATELETS: 225 thou cells/ ul | WBC WHITE BLOOD CELLS: 729 K/uL | FASTING PLASMA GLUCOSE (FPG): 173 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 9.5 % | URINE MICROALBUMINURIA: 0.8 mg/L | BICARBONATE: 23 meq/L | CHLORIDE: 101 meq/L | POTASSIUM: 4.2 meQ/L | SODIUM: 137 meq/L | CREATININE: 0.8 mg/dL | UREA: 15.9 mg/dL | URIC ACID: 5.2 | HDL HIGH DENSITY LIPOPROTEIN: 25 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 41 mg/dL | TGL TRIGLYCERIDE: 164 mg/dL | TOTAL CHOLESTEROL: 86 mg/dl | EGFR EGLOMERULAR FILTRATION RATE: 112.34 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 112.34 mL/min/1.73m2 | ALBUMIN (SERUM): 4.8 g/dL | ALKALINE PHOSPHOTASE: 55 IU/L | DIRECT BILIRUBIN: 0.5 mg/dl | SGOT (AST): 31 U/L | SGPT (ALT): 57 IU/L | FIB4: 0.79 | TOTAL BILIRUBIN: 1.2 mg/dL | TESTOSTERONE (TOTAL): 324 ng/dL | POST PRANDIAL GLUCOSE (2HPP): 346 mg/dL | TOTAL T3: 111 | TOTAL T4: 7.2 mcg/dL | TSH : 3.3 mIU/L | VITAMIN B12: 674 pg/mL | VITAMIN D (25 OH): 19 ng/mL |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
DEGLUDEC (INJ U100)
TRESIBA
Medicine For DIABETES |
SQ |
20-0-0 UNITS |
AFTER FOOD
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
2 |
CHOLECALCIFEROL 2000 IU
D RISE 2000 IU
Medicine For VITAMIN D |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| TAKE AT BEDTIME | |
|
3 |
INJECTION FAST ASPART (INJ U100)
FIASP
Medicine For GLUCOSE CONTROL |
SQ |
8-6-6 UNITS |
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
4 |
SAROGLITAZAAR 4 MG
LIPAGLYN 4 MG |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE EDEMA AND WEIGHT GAIN | |
|
5 |
TELMISARTAN 40 MG
ERITEL 40 MG |
|
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE HIGH POTASSIUM | |
|
6 |
CAPSULE SEMAGLUTIDE
SEMASIZE 0.25
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA VOMITING VISUAL DISTURBANCE | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 21/Aug/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP SMBG |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
This is a Computer generated Prescription |
Powered By:  |